Welcome to LookChem.com Sign In|Join Free
  • or
5-(4-Methoxyphenyl)pyridin-3-aMine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1225522-97-3

Post Buying Request

1225522-97-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1225522-97-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1225522-97-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,5,5,2 and 2 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1225522-97:
(9*1)+(8*2)+(7*2)+(6*5)+(5*5)+(4*2)+(3*2)+(2*9)+(1*7)=133
133 % 10 = 3
So 1225522-97-3 is a valid CAS Registry Number.

1225522-97-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(4-methoxyphenyl)pyridin-3-amine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1225522-97-3 SDS

1225522-97-3Relevant academic research and scientific papers

FNEW ACTIVATORS OF SIRT1 ENZYME FOR THE TREATMENT OF CARDIOVASCULAR AND CARDIOMETABOLIC PATHOLOGIES

-

Page/Page column 18; 32-34, (2019/09/12)

This invention describes a class of compounds able to activate the human SIRT1 enzyme and regulate many metabolic functions. This invention relates to compounds that can be employed in medical applications, specifically for the treatment or prevention of cardiometabolic diseases, such as diabetes, and of cardiovascular disorders, such as coronaropathy, heart failure and atherosclerosis.

SULFONAMIDE COMPOUNDS AND USES AS TNAP INHIBITORS

-

Paragraph 00279, (2013/09/12)

Described herein are compounds that modulate the activity of TNAP. In some embodiments, the compounds described herein inhibit TNAP. In certain embodiments, the compounds described herein are useful in the treatment of conditions associated with hyper- mineralization.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1225522-97-3